GUTS
Fractyl Health Inc.

1,792
Mkt Cap
$64.31M
Volume
1.84M
52W High
$3.03
52W Low
$0.3772
PE Ratio
-0.21
GUTS Fundamentals
Price
$0.4693
Prev Close
$0.4747
Open
$0.4731
50D MA
$1.41
Beta
1.27
Avg. Volume
9.79M
EPS (Annual)
-$1.44
P/B
-19.52
Rev/Employee
$869.16
$95.47
Loading...
Loading...
News
all
press releases
Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Fractyl Health, Inc. (GUTS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday
Fractyl Health (NASDAQ:GUTS) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·7d ago
News Placeholder
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Increases By 22.6%
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 14,901,084 shares, a growth...
MarketBeat·13d ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) have received a consensus rating of "Hold" from the five brokerages that are currently covering the firm, Marketbeat.com reports. One...
MarketBeat·24d ago
News Placeholder
Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights GUTS
The DJS Law Group announces that it is investigating claims on behalf of investors of Fractyl Health, Inc. (Fractyl Health or the Company) (NASDAQ: GUTS) for violations of the securities laws...
Business Wire·1mo ago
News Placeholder
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain
Fractyl Health (NASDAQ:GUTS) presented prospective, randomized, double-blind, controlled six-month data from its REMAIN-1 midpoint cohort pilot study, highlighting results the company said support...
MarketBeat·1mo ago
News Placeholder
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study?
Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.
Stocktwits·1mo ago
News Placeholder
HC Wainwright Forecasts Fractyl Health FY2030 Earnings
Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) - Equities researchers at HC Wainwright issued their FY2030 EPS estimates for Fractyl Health in a research report issued to clients and investors on...
MarketBeat·1mo ago
News Placeholder
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 24.0%
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 11,893,654 shares, a growth...
MarketBeat·1mo ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five research firms that are covering the firm, MarketBeat reports. One...
MarketBeat·2mo ago
<
1
2
...
>

Latest GUTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.